[A clinico-biochemical study of acute encephalopathy in patients treated with Ca-hopantenate].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001774:Blood Chemical Analysis; D001927:Brain Diseases / Q000097:blood / Q000139:chemically induced*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010205:Pantothenic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D012202:Reye Syndrome / Q000097:blood / Q000139:chemically induced; D014635:Valproic Acid / Q000009:adverse effects; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
C016030:pantogab; D010205:Pantothenic Acid; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid